666

BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD.

No trades
See on Supercharts

688621 fundamentals

BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 688621 for the last quarter is 230.55 M CNY, and it's 0.99% higher compared to the previous quarter. The net income of Q3 23 is 53.08 M CNY.

Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth